Xeloda Approved for Advanced Breast Cancer
The FDA approved Hoffmann La Roche Xeloda for some advanced breast cancer patients under a fast track program. Early studies show tumor shrinkage in patients who exhausted other options, with a convenient pill form offering potential quality of life gains. Xeloda reaches pharmacies in May. pricing undetermined.
MENTIONED IN THIS ARTICLE
Washington
Hoffman-La Roche
Food and Drug Administration
FDA
Cathy Adelson
Houston
Adelson
Drug therapy after heart attack improves 10 year survival
Large international study shows streptokinase and daily aspirin given after heart attack increase long term survival. Of 17 187 patients in 16 countries, about 40 extra survivors per 1000 treated over ten years, with benefits seen even in the elderly. Oxford University researchers published in BMJ.
MENTIONED IN THIS ARTICLE
London
Oxford University
British Medical Journal
Also Mentioned on This Page
Xelada
Britain
Iowa
the Gazette
Cedar Rapids
Fri
Phelan
Third Avenue
Act Teje
Orie
Sprint
Tauil
Aeah
RadioShack
Nhs
Pana
Sore Pet Et
Lee
Shack
Los Angeles